Having found that the chemical inhibitor of cathepsin L can increase GCase protein level in the iPSC-dopaminergic neurons, we next asked whether the SB 412515 could correct GCase level in a dopaminergic neuronal PD model of GCase-deficiency. This evidence concerns the gene CTSL and Parkinson disease.